Clinitech Laboratory Ltd Share Price

₹35.00 0.00 (0.00%) BSE
as updated on 30-Mar-2026 16:59 | Sector - Healthcare

Day Range

  • Day's Low:0.00
  • Day's High:0.00

  • 52 Week Low28.55
  • 52 Week High57.00

Clinitech Laboratory Ltd's key Fundamentals

Market Cap ₹8 Cr.
P/E Ratio 20.2
TTM EPS 1.7
P/B Ratio 0.90
ROE 5.61
Debt to Equity 0.00
Face Value 10
BVPS 38.7
3 Year Sales Growth 8.86%

Clinitech Laboratory Ltd's Share Price Returns

1 Day 0.00%
1 Week 0.00%
1 Month 0.00%
3 Months -15.70%
6 Months 0.00%
1 Years -8.40%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Clinitech Laboratory Ltd Shareholding Pattern

Promoters

(62.42%)

Institutions

(0.32%)

Non-Institutions

(37.27%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Clinitech Laboratory Ltd

The company was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The status of the company was changed to public limited and the name of the company was changed to Clinitech Laboratory Limited vide Special Resolution dated July 24, 2023 pursuant to conversion of the Company into public limited Company. The fresh certificate of incorporation consequent to conversion was issued on August 25, 2023 by the Registrar of Companies, Mumbai.

The company is a provider of diagnostic and healthcare tests and services through chain of several diagnostic centers in and around Thane and Navi Mumbai. Its Promoters have many years of experience in diagnostic business. It conducts lakhs of tests per year in its NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs equipped with modern technology and high-end equipment. It conducts various tests at its centres which are classified under various heads as under: Biochemistry tests; Immunology tests; Hematology tests; Molecular Biology tests; Serology tests; Microbiology tests; and Histopathology tests.  

Business area of the company

The company is one of the most trusted diagnostic centers & pathology labs.

Major Events and Milestones

  • 2010: Incorporation of the company.
  • 2012: Established new Lab at Kalyan.
  • 2016: NABL Accreditation at Airoli Centre.
  • 2018: Established new Lab at Thane.
  • 2021: NABL Accreditation for SARS-COV-2 testing.
  • 2021: Signed up agreements for Diagnostic Centre at Kharghar.
  • 2022: Signed up agreements for Diagnostic Centre at Panvel / Badlapur.
  • 2023: Converted Company to Limited.
  • 2023: Established new Lab at Murbad and Panvel. 


Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 0.00
  • Day's High: 0.00

  • 52 Week Low28.55
  • 52 Week High57.00

Clinitech Laboratory Ltd's key Fundamentals

Market Cap ₹8 Cr.
P/E Ratio 20.2
TTM EPS 1.7
P/B Ratio 0.90
ROE 5.61
Debt to Equity 0.00
Face Value 10
BVPS 38.7
3 Year Sales Growth 8.86%

Clinitech Laboratory Ltd's Share Price Returns

1 Day 0.00%
1 Week 0.00%
1 Month 0.00%
3 Months -15.70%
6 Months 0.00%
1 Years -8.40%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Investment related blogs

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×